Breaking News
Top News
-
BOJ Flags Risk to Japan Bonds From Foreign Hedge Funds Unwinding
-
Taylor says 25% gas levy would shut industry; more unopened votes in SA – as it happened
-
King Charles pays tribute to late mother on 100th anniversary of her birth
-
Apple chief Tim Cook to hand over to John Ternus in September
-
National Australia Bank flags $503 million impairment hit on Mideast volatility
-
Spyre (SYRE) Climbs 42% as Treatment Candidate Poses ‘Best-in-Class’ Potential
-
The end of freedom of the seas: Why global shipping may never be the same
-
Stocks and Bonds Steady as Attention Turns to Iran Talks
-
France Sees Up to €6 Billion Budget Impact From Iran War
-
UN Agency Prepares Hormuz Evacuation Plan for Hundreds of Ships
-
AI Optimism Pushing Stocks Higher Despite Iran Risks: 3-Minutes MLIV
-
Ex-Swedbank CEO Bonnesen Fully Cleared in Dirty Money Case
-
Swiss Watch Exports Dipped in March Amid Iran War and High Costs
-
Commerzbank Rejects UniCredit’s ‘Hostile’ Approach
-
Primark to split from food business despite warning of Iran war impact
-
Music executive behind K-pop group BTS faces arrest in South Korea
-
Middle East Oil Pricing Is Cracking Under Pressure
-
Regeneron Pharmaceuticals (REGN) Announces Collaboration With Telix Pharmaceuticals Limited
-
Raymond James Resumes Coverage of Jazz Pharmaceuticals (JAZZ) With an Outperform Rating
-
Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now
2026-02-05

































